Friday, September 22, 2023  |



Thomas Hauser issues statement with regard to USADA comments

Fighters Network

The following statement is from noted author and journalist Thomas Hauser with regard to the September 10, 2015, comments by Annie Skinner on behalf of USADA (which disputed several allegations made in a recent article examining the anti-doping agency’s PED-testing practices in professional boxing and with regard to Floyd Mayweather Jr.):

No amount of self-serving rhetoric from USADA can change the following unrebutted facts:

(1) The IV was administered at Floyd Mayweather’s home after the weigh-in on May 1. USADA learned about the IV on that date.

(2) The 2015 WADA “Prohibited Substances and Methods List” states, “Intravenous infusions and/or injections of more than 50 ml per 6 hour period are prohibited except for those legitimately received in the course of hospital admissions, surgical procedures, or clinical investigations.”

(3) The above-referenced prohibition is in effect at all times that the athlete is subject to testing. It exists because, in addition to being administered for the purpose of adding specific substances to a person’s body, an IV infusion can dilute or mask the presence of another substance that is already in the recipient’s system or might be added to it in the near future.

(4) Mayweather-Pacquiao was contested on May 2.

(5) Mayweather applied for a therapeutic use exemption on May 19 (seventeen days after the fight).

(6) USADA granted the therapeutic use exemption on May 20 (eighteen days after the fight).

(7) USADA did not notify the Nevada State Athletic Commission about the IV until May 21 (nineteen days after the fight).


Meanwhile, on May 2 (fight night), Manny Pacquiao’s request to be injected with Toradol (a legal substance) to ease the pain caused by a torn rotator cuff was denied by the Nevada State Athletic Commission because the request was not made in a timely manner.

It would be helpful if (USADA CEO) Travis Tygart or his spokesperson answered the following questions directly:

(1) What was the medical justification and supporting data that led to USADA granting the therapeutic use exemption for an otherwise prohibited IV procedure?

(2) On how many occasions has the “A” sample of a professional boxer tested by USADA come back positive for a prohibited substance?

(3) What was the testosterone-to-epitestosterone ratio for each urine test administered to Floyd Mayweather by USADA for each of his fights beginning with Mayweather vs. Shane Mosley up to and including Mayweather vs. Andre Berto?

(4) Does USADA still maintain that it handled the Erik Morales matter correctly?